O
IPXL

OppenheimerFunds’s Impax Laboratories, Inc. IPXL Stock Holding History

OppenheimerFunds’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,566
Closed -$439K – 1852
2018
Q1 		$439K Sell
22,566
-6,914
-23% -$136K ﹤0.01% 1457
2017
Q4 		$491K Buy
29,480
+3,977
+16% +$72.9K ﹤0.01% 1523
2017
Q3 		$517K Sell
25,503
-17,427
-41% -$333K ﹤0.01% 1504
2017
Q2 		$691K Sell
42,930
-22,593
-34% -$334K ﹤0.01% 1347
2017
Q1 		$828K Buy
65,523
+22,521
+52% +$272K ﹤0.01% 1252
2016
Q4 		$570K Sell
43,002
-214,513
-83% -$3.67M ﹤0.01% 1314
2016
Q3 		$6.1M Buy
257,515
+10,141
+4% +$273K 0.01% 799
2016
Q2 		$7.13M Buy
247,374
+6,377
+3% +$208K 0.01% 765
2016
Q1 		$7.72M Buy
240,997
+232,275
+2,663% +$8.17M 0.01% 758
2015
Q4 		$373K Buy
+8,722
New +$348K ﹤0.01% 1419

OppenheimerFunds's IPXL Position: Q2 2018 in Review

OppenheimerFunds sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 22,566 shares — an estimated $439K sold.

OppenheimerFunds first reported a position in IPXL in Q4 2015 and held it in 10 quarters. The position peaked at $7.72M in Q1 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • OppenheimerFunds reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • OppenheimerFunds sold 22,566 Impax Laboratories, Inc. shares in Q2 2018, an estimated $439K.
  • OppenheimerFunds first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 10 quarters.
  • OppenheimerFunds's Impax Laboratories, Inc. position peaked at $7.72M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on OppenheimerFunds's 13F filing for Q2 2018, filed 13 Aug 2018.